Buechner, Jochen Et Al. Global Registration Trial Of Efficacy And Safety Of Ctl019 In Pediatric And Young Adult Patients With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (All): Update To The Interim Analysis. June 24, 4:00 Pm CEST. European Hematology Association: Abstract S476.
Campana, Dario. Minimal Residual Disease in Acute Lymphoblastic Leukemia. Seminars in hematology 46.1 (2009): 100–106. PMC. Web. 22 May 2017.
Satwani, Prkash, Sather, Harland, Ozkaynak, Fevzi, et al. Allogeneic Bone Marrow Transplantation in First Remission for Children with Ultra-high-risk Features of Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study Report." Biology of Blood and Marrow Transplantation 13.2 (2007): 218-27. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731715/. Accessed June 2017.